. Author manuscript; available in PMC: 2023 Jul 3.

Published in final edited form as: Stem Cell Res. 2022 Jan 3;59:102657. doi: 10.1016/j.scr.2022.102657

1.

Resource table

Unique stem cell lines identifier	1) SCVIi039-A
	2) SCVIi040-A
	3) SCVIi041-A
Alternative name(s) of stem cell lines
Institution	Stanford Cardiovascular Institute, Stanford, CA, USA
Contact information of distributor	Joseph C. Wu
Contact information of distributor	joewu@stanford.edu
Type of cell lines	iPSC
Origin	Human
Additional origin info required	SCVIi039-A: 74 y/o male, Caucasian SCVIi040-A: 76 y/o male, Caucasian SCVIi041-A: 48 y/o female, Caucasian
Cell Source	Blood-isolated peripheral blood mononuclear cells (PBMCs)
Clonality	Clonal
Method of reprogramming	Sendai virus vector
Evidence of the reprogramming transgene loss (including genomic copy if applicable)	RT-qPCR
Type of Genetic Modification	N/A
Cell culture system used	Feeder-free cell culture
Associated disease	Dilated cardiomyopathy (DCM)
Gene/locus	LMNA mutation p.Arg133Gln (c.398 G > A)
Date archived/stock date	November 12th, 2021
Cell line repository/bank
Ethical approval	https://hpscreg.eu/cell-line/SCVIi039-A https://hpscreg.eu/cell-line/SCVIi040-A https://hpscreg.eu/cell-line/SCVIi041-A The generation of the lines was approved by the Administrative Panel of Human Subjects Research under IRB #29904 “Derivation of Human Induced Pluripotent Stem Cells (Biorepository)”.